Differences in classification of intermediate risk (26.7% and 17.8% for RS and RSPC, respectively) may be significant, given the lack of clear treatment guidance for this group.
1
—
—
Differences in classification of intermediate risk (26.7% and 17.8% for RS and RSPC, respectively) may be significant, given the lack of clear treatment guidance for this group.